Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J. Aguirre, William C. Hahn, Barbara A. Weir et al.|Cancer Discovery|2016Cited by 632
Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cellsMihir B. Doshi, Dohoon Kim|Nature|2023Cited by 51